Leaky Gut Syndrome: What It Is, What We Actually Know, and How To Support Your Gut

If you have spent any time reading about digestive health online, you have probably come across the term "leaky gut." It sounds alarming, and the claims surrounding it range from reasonable to wildly exaggerated. This article breaks down what intestinal permeability actually means, which conditions it is linked to, what the research says about testing and treatment, and how to support your gut lining with evidence-based strategies.

Key Takeaways

• "Leaky gut" is a popular name for increased intestinal permeability, a measurable biological phenomenon in which the gut barrier allows more luminal material to cross than usual. Leaky gut syndrome is a proposed gastrointestinal disorder, but it is not a recognized medical diagnosis.
• Increased intestinal permeability has been observed in conditions such as inflammatory bowel disease, celiac disease, some irritable bowel syndrome subtypes, and some metabolic and liver disorders. In most cases, it is a component of disease, not the single root cause.
• There is no validated universal protocol or fixed timeline for "healing leaky gut." The priority is to identify and treat any underlying condition.
• A varied, minimally processed diet, regular sleep and movement, stress management, and avoiding unnecessary supplements or extreme restrictive diets can support general gut health, but none is a stand-alone cure for intestinal permeability.
• No blood, stool, or urine test is currently validated to diagnose leaky gut syndrome as a stand-alone condition.

What Is Leaky Gut Syndrome, Exactly?

Leaky gut syndrome is a popular, non-medical label for a state of increased intestinal permeability in the small and large intestines. In simple terms, the intestinal lining acts as a selectively permeable wall: it regulates the passage of water, ions, nutrients, antigens, microbial products, and other material between the intestinal lumen and the body.

In science and medicine, the preferred terms are intestinal permeability, intestinal hyperpermeability, or intestinal barrier dysfunction. Aspects of permeability and barrier function are measurable and actively studied. Barrier dysfunction is associated with chronic diseases like inflammatory bowel disease and celiac disease, but scientists still debate how much it causes disease versus results from it.

The medical community, including major gastroenterology societies, does not currently recognize leaky gut syndrome as a stand-alone diagnosis. Research continues to refine how barrier function is measured and how it relates to different diseases.

The Intestinal Barrier: How Your Gut Lining Actually Works

Your gut lining is a thin, constantly renewing sheet of cells. When its folds, villi, and microvilli are included, the adult digestive tract's inner mucosal surface has been estimated at roughly 32 square meters, or about 340 square feet, comparable to half a badminton court.
The intestinal barrier has several coordinated layers working together:

• Microbial layer: The gut microbiota, a community of bacteria, fungi, and viruses, competes with harmful bacteria and produces beneficial compounds.
• Mucus and chemical layer: Mucus, antimicrobial peptides, and secretory IgA trap and neutralize microbes before they reach the cells underneath.
• Physical cell layer: Intestinal epithelial cells connected by tight junctions form the core physical barrier. Goblet cells secrete mucus; Paneth cells release antimicrobial molecules.
• Immune layer: Immune cells (T cells, B cells, macrophages, dendritic cells) sit just below the surface, sensing breaches and deciding whether to tolerate or attack what crosses.

Permeability is not all or nothing. A healthy digestive system is somewhat permeable, and this is by design. The gut actively regulates what crosses from the intestinal tract into the body.

Intestinal Permeability and Tight Junctions

Tight junctions are microscopic protein structures that seal the spaces between neighboring intestinal epithelial cells. Think of them as adjustable zippers that control paracellular transport, the movement of water and small molecules between cells. Key tight junction proteins include claudins, occludin, and zonula occludens-1 (ZO-1). Together, they decide how "tight" or "leaky" the barrier is at any moment.

Tight junctions help regulate the paracellular movement of water, ions, and some small solutes. Most nutrients, however, are absorbed through transporters that move them across intestinal cells. Inflammatory signals (like TNF and IL-1 beta), gut microbes, hormones, and dietary components can influence tight junction behavior through pathways like MLCK (myosin light chain kinase) and NF-kB. When these proteins are disrupted or their composition changes, intestinal permeability may increase.

Barrier disruption can increase contact between immune cells and microbial products or dietary antigens. Intact bacteria may also cross at sites of epithelial injury. These events can promote local immune activation and, in some disease settings, may contribute to systemic inflammation. The effect depends on the underlying condition, and increased permeability can be either a contributor to disease or a consequence of it.

The Gut Microbiome's Role in Leaky Gut

The gut microbiome is the community of trillions of microbes living mainly in the colon, with dominant bacterial phyla like Firmicutes and Bacteroidetes. Microbial communities and their metabolites can support the intestinal barrier by competing with pathogens, interacting with the immune system, and producing compounds like short-chain fatty acids (SCFAs), particularly butyrate.

Dysbiosis is a broad term for condition-associated changes in microbial composition or function. Depending on the condition, these changes may affect short-chain fatty acid production, mucus, and inflammatory signaling. There is no single universal dysbiosis pattern, and in many studies it remains unclear whether microbiome changes cause barrier dysfunction, result from disease, or both.

A diverse range of plant foods can supply substrates for gut microbes. Research has linked microbiome changes and barrier dysfunction with inflammatory bowel disease (IBD), obesity, metabolic dysfunction-associated steatotic liver disease (MASLD, formerly called non-alcoholic fatty liver disease), and some cardiometabolic conditions. Cause-and-effect is still being clarified.

Conditions Associated With Increased Intestinal Permeability

Increased intestinal permeability has been observed across digestive and non-digestive diseases, but the strength of evidence and causal direction vary. Here are the most well-studied associations.

Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)

Inflammatory bowel disease is a chronic inflammatory condition of the gastrointestinal tract, including Crohn's disease and ulcerative colitis. Studies consistently find increased intestinal permeability in people with IBD compared with healthy controls. Even symptom-free first-degree relatives of people with Crohn's disease sometimes show elevated permeability, suggesting that barrier changes can precede disease in a subset, although genetic and environmental contributions remain under study.

In active disease, tight junction protein patterns change: barrier-forming claudins and occludin decrease while claudin-2, a more "leaky" pore-forming protein, increases. Bacterial components crossing the compromised intestinal mucosa can fuel chronic inflammation through continuous activation of the immune system in the intestinal wall.
Standard IBD treatments, such as biologic anti-TNF therapies, can reduce intestinal permeability as gut inflammation improves. This supports the idea that controlling the disease can also help restore barrier function.

Irritable Bowel Syndrome and Functional Digestive Disorders

Irritable bowel syndrome is a common functional digestive disorder characterized by abdominal pain and altered bowel habits, affecting an estimated 5 to 10 percent of the population worldwide. Common symptoms include bloating, diarrhea, and constipation.

Some IBS subtypes, especially diarrhea-predominant IBS (IBS-D) and postinfectious IBS, show modest increases in intestinal permeability. A systematic review of 66 studies found intestinal permeability defects in 37 to 62 percent of IBS-D patients and 17 to 50 percent of those with postinfectious IBS, much higher than healthy controls. The studies were heterogeneous, and barrier changes were not present in every patient.

A low-FODMAP diet can relieve IBS symptoms in some people. But improving digestive health in IBS usually requires a combination of diet personalization, stress reduction, and sometimes targeted medications, not just focusing on "fixing leaky gut."

Celiac Disease and Gluten: Where Zonulin Comes In

Celiac disease (also called coeliac disease) is an autoimmune condition in which gluten ingestion triggers immune-mediated damage to the small intestine lining in genetically susceptible people. Leaky gut is linked to inflammatory bowel disease and celiac disease, both of which show clear barrier dysfunction.

Zonulin has been proposed as a regulator of tight junction signaling, and gliadin can trigger zonulin-related pathways in celiac disease. However, zonulin biology and measurement are more complex than this simplified model suggests. Widely used commercial assays may not accurately measure pre-haptoglobin-2, the protein identified as zonulin.

Commercial blood or stool "zonulin tests" marketed for leaky gut in the general population are not standardized or well validated. For people with confirmed celiac disease, a strict lifelong gluten-free diet is the established treatment. It allows intestinal healing in most patients, while ongoing medical and dietitian follow-up is recommended.

Beyond The Gut: Metabolic, Liver, and Autoimmune Conditions

Altered permeability markers and microbiome patterns have been observed in obesity, type 2 diabetes, MASLD, and some cardiovascular populations. Results vary by condition and testing method, and an association does not show that barrier dysfunction caused the disease.

One proposed mechanism involves bacterial products such as lipopolysaccharide (LPS) reaching the circulation and contributing to low-grade immune activation. Measuring low concentrations of LPS in human blood is technically difficult, however, and the clinical importance of this pathway remains under study.

Barrier changes have also been studied in type 1 diabetes, multiple sclerosis, and rheumatoid arthritis. Current evidence is mainly associative or mechanistic and does not support the claim that increased intestinal permeability alone causes these complex autoimmune disorders.

Supporting overall gut health may complement care for metabolic and autoimmune conditions, but it should never replace evidence-based medical treatment.

Controversies and Myths About Leaky Gut Syndrome

"Leaky gut" is heavily discussed on social media and in alternative medicine, often with oversimplified or exaggerated claims. Here are three myths worth addressing:
Myth 1: Leaky gut is the root cause of almost every chronic symptom. Increased intestinal permeability is documented in certain diseases, but there is no evidence that it is the universal root cause of chronic symptoms. Fatigue, headaches, brain fog, rashes, and joint pain are often attributed to leaky gut online, but they are non-specific and cannot diagnose intestinal permeability. Digestive symptoms such as bloating, gas, and discomfort also have many possible causes.
Myth 2: Any bloating or brain fog automatically means a leaky gut. These symptoms need proper medical evaluation. Nutritional deficiencies can occur in diseases that damage the intestinal mucosa, such as celiac disease or IBD, but they are not proof of increased permeability. Food intolerances, food allergies, gastrointestinal disorders, and mental health conditions can produce overlapping symptoms.
Myth 3: A supplement stack can "seal" your gut in days. The intestinal epithelium renews every 3 to 7 days, but cell turnover is not a clock for recovery from an underlying disease or barrier abnormality. Timelines vary by cause, severity, and treatment response. Be cautious with practitioners or companies who diagnose leaky gut syndrome based on unvalidated tests or sell expensive "cures" without discussing evidence.

Testing for Intestinal Permeability: What We Can and Cannot Measure

There is no single, widely accepted clinical test that can diagnose leaky gut syndrome as a disease. However, several research tools assess intestinal permeability.

The classic lactulose-mannitol test involves drinking a solution of two sugars and measuring how much of each appears in urine. The lactulose-to-mannitol ratio is used as an indirect estimate of small-intestinal permeability, but protocols and reference ranges vary. Results can be affected by factors such as gastric emptying, kidney function, urine collection time, hydration, and analytical method, so a single universal "normal" cutoff is not appropriate.

Other research approaches include biopsies with Ussing chambers, confocal endomicroscopy, and blood markers such as D-lactate or LPS-binding protein. These markers are indirect, have important limitations, and are not validated as stand-alone tests for leaky gut syndrome in everyday clinical care.

Commercial blood and stool tests claiming to measure zonulin, LPS antibodies, or "intestinal barrier panels" often lack robust validation and standardized reference ranges. If you have ongoing digestive symptoms, consult a gastroenterologist who can rule out conditions like celiac disease, inflammatory bowel disease, and infections with appropriate, validated tests.

Core Principles To Improve Gut Health and Support the Intestinal Barrier

This is the practical heart of the article. Treatment strategies focus on managing underlying gastrointestinal conditions and dietary modifications. Here are the main pillars:

1. Treat underlying disease first (IBD, celiac disease, infections).
2. Build a fiber-rich, minimally processed diet.
3. Manage chronic stress.
4. Move your body regularly.
5. Sleep well.
6. Use supplements thoughtfully and only when supported by evidence.

There is no evidence-based universal timeline for restoring intestinal barrier function. These habits can support overall health while condition-specific treatment addresses the underlying cause.

Dietary Patterns That Support the Gut Lining

Focus on overall diet patterns rather than single superfoods. Mediterranean-style, whole-food, or plant-forward approaches support overall cardiometabolic and digestive health. Diets rich in vegetables, fruits, legumes, nuts, seeds, whole grains, and healthy fats provide fibers, polyphenols, and micronutrients, although direct evidence that any one pattern normalizes intestinal permeability is limited.

Dietary fiber supports bowel function and microbial fermentation, including production of short-chain fatty acids. Its effects on microbial diversity and permeability vary by fiber type, dose, individual tolerance, and health condition. Dietary adjustments can include gradually increasing tolerated fiber-rich foods and reducing ultra-processed foods.

Limiting foods high in added sugars, refined carbohydrates, and ultra-processed ingredients is consistent with general healthy-eating guidance, but no specific "leaky gut diet" has been proven. A balanced plate with a variety of plant foods is a practical starting point when medically appropriate and well tolerated.

Fibers, Prebiotics, and Short-Chain Fatty Acids

Dietary fiber and prebiotics are parts of plant foods that humans cannot digest but gut bacteria can ferment. This fermentation generates short-chain fatty acids: acetate, propionate, and butyrate. Many fermentable fibers promote the production of short-chain fatty acids, which serve as fuel for colon cells and help regulate intestinal function and immune responses.

Butyrate in particular is a key energy source for colonocytes (colon lining cells). It can enhance tight junction integrity, support mucus production, and reduce local gut inflammation in experimental models.

Everyday food sources include oats, barley, beans, lentils, chickpeas, onions, garlic, leeks, asparagus, green bananas, and cooked-and-cooled potatoes. Increase fiber gradually and adjust the type and amount to your tolerance. People with IBS or active IBD may need individualized guidance because some high-fiber foods can worsen symptoms.

Probiotics, Fermented Foods, and the Gut Microbiome

Probiotics are live microorganisms that, when consumed in adequate amounts, may provide health benefits. Strain, dose, and health condition matter. Some probiotic interventions have influenced permeability-related markers, but human results are inconsistent and cannot be generalized across products or conditions.

Accessible fermented foods like yogurt with live cultures, kefir, sauerkraut, and kimchi can be part of a varied diet if tolerated, but they are not proven treatments for intestinal permeability. Probiotics are not risk-free for everyone, especially in severely immunocompromised patients. View them as one tool among many, not a stand-alone leaky gut cure.

FODMAPs, Food Intolerances, and When To Restrict

FODMAPs are fermentable carbohydrates that can trigger bloating, gas, and pain in some people with irritable bowel syndrome. A limited trial of a low-FODMAP diet can improve global IBS symptoms in some patients, but it should be a structured, short-term intervention followed by reintroduction and personalization, not a lifelong highly restrictive plan. Short-term reductions in Bifidobacteria have been reported, while longer-term microbiome and short-chain fatty acid effects remain uncertain.

These carbohydrates are not inherently "bad." Many act as prebiotics in people without IBS. Avoid eliminating entire food groups like gluten or dairy without a clear medical reason or professional guidance, since this can increase the risk of nutrient inadequacy and may not address the true cause. Keep a simple symptom diary and, if possible, work with a nutrition professional for structured elimination and reintroduction.

Key Nutrients and Bioactives Studied for Intestinal Barrier Support

Supplements are sometimes studied as adjuncts, but they do not replace diet, lifestyle, or condition-specific medical care. The most studied categories for intestinal permeability include:

• Glutamine: An amino acid used by intestinal epithelial cells. One randomized trial found symptom and permeability-marker improvements in a selected group with postinfectious IBS-D and documented hyperpermeability, but larger confirmatory trials are needed. This result should not be generalized to all IBS or Crohn's disease.
• Zinc: A small 2025 patient-based study in otherwise healthy participants used separate cohorts for different surrogate endpoints and found changes in tight junction-related genes and proteins plus lower D-lactate after short-term zinc gluconate. It did not test symptom or disease outcomes, and the dose exceeded the adult tolerable upper intake level of 40 mg per day, so it is not a basis for self-supplementation.
• Vitamins A and D: These nutrients have roles in epithelial and immune physiology, but supplements have not been shown to "heal leaky gut" in people without a deficiency. Excess vitamin A can be toxic, and high-dose vitamin D also carries risks.
• Polyphenols: Compounds like quercetin and curcumin show antioxidant and anti-inflammatory effects on intestinal tissue in preclinical models.

Evidence is not yet strong enough to recommend these as universal leaky gut cures. Supplement use should be individualized, time-limited, and ideally supervised by a clinician.

Lifestyle Factors: Stress, Sleep, Movement, and Alcohol

The gut brain axis links psychological stress with digestive function and intestinal barrier behavior through neural, hormonal, and immune pathways. Stress can alter barrier-related processes in experimental models, while human evidence is less definitive. Stress-management strategies can still help symptom control and overall well-being, especially in disorders such as IBS.

Short sleep duration and irregular sleep patterns have been associated with microbiome and metabolic changes, but sleep has not been proven to repair intestinal permeability. For most adults, roughly 7 to 9 hours of regular sleep is a reasonable general health target.
Moderate, regular physical activity supports overall and digestive health. Excessive, unaccustomed high-intensity exercise without recovery can transiently increase gut permeability, especially in hot conditions.

Heavy alcohol use can damage the intestinal barrier. Both acute high-dose exposure and chronic heavy drinking can alter the gut microbiome, injure intestinal epithelial cells, and increase translocation of bacterial products to the liver and bloodstream.

Medications, Infections, and Other Triggers That Can Affect the Gut Lining

Certain medications can affect the intestinal barrier, including nonsteroidal anti-inflammatory drugs like ibuprofen, especially at high doses or with long-term use. The risk depends on the medication, dose, duration, and individual susceptibility.
Antibiotics can disrupt the gut microbiome, but their effect on intestinal permeability varies by drug and clinical context, and much of the mechanistic evidence comes from experimental studies. Gastrointestinal infections can directly injure intestinal tissue, and some people develop postinfectious irritable bowel syndrome with lingering barrier changes. Helicobacter pylori primarily affects the stomach's mucosal barrier rather than serving as a general example of small-intestinal "leakiness."

Do not stop prescribed medications on your own because of leaky gut concerns. Talk with your prescriber about risks, benefits, and possible alternatives. Good food hygiene and safe water practices can reduce the risk of some infection-related gut injury.

How Long Does It Take To "Heal" a Leaky Gut?

Because leaky gut syndrome is not a formal diagnosis, there is no standard healing timeline. Intestinal permeability can fluctuate even in healthy people depending on diet, exercise, infections, and stress.

The intestinal epithelium renews itself roughly every 3 to 7 days, but this turnover rate does not determine how quickly an underlying disease or permeability abnormality will improve. Treatment response varies widely, and feeling better does not prove that barrier function has normalized.

Recovery is rarely a straight line. Occasional symptom flares do not mean all progress is lost. Focus on patterns over time and track relevant indicators such as stool pattern and pain levels, along with disease-specific medical markers when appropriate. For example, calprotectin tracks intestinal inflammation in IBD, not intestinal permeability itself.

Practical 4-Step Framework To Support Your Gut Lining

Here is a simple, memorable framework. It is not a proprietary protocol; it is a practical way to organize evidence-based habits.

1. Identify: Seek medical evaluation for persistent symptoms or red flags, and identify any underlying condition rather than assuming leaky gut syndrome.
2. Treat: Follow evidence-based care for diagnosed infections, IBD, celiac disease, IBS, or other conditions. Do not stop prescribed medications without speaking with your clinician.
3. Support: Build meals around tolerated whole plant foods, adequate protein, healthy fats, and hydration. Increase fiber gradually, and avoid universal exclusion lists or unneeded restriction.
4. Reassess: Track symptoms, nutritional adequacy, and condition-specific markers with your care team. Adjust the plan according to response rather than following a fixed "gut-healing" timeline.

When To See a Doctor and What To Ask

Seek prompt medical evaluation for red flag symptoms:

• Unintentional weight loss
• Blood in the stool or black tarry stools
• Persistent vomiting or fever
• Night sweats or difficulty swallowing
• Strong family history of colon cancer or inflammatory bowel disease

If you have long-standing symptoms like daily diarrhea, severe bloating, suspected food reactions, or significant self-imposed food restriction, seek gastroenterology input rather than only self-treating with supplements labeled for leaky gut.

Practical questions to bring to appointments: "Could conditions like celiac disease, inflammatory bowel disease, or microscopic colitis explain my symptoms?" and "Which tests are truly useful in my case?" Share any supplements you are taking so your clinician can check for interactions. Collaborative discussion is usually more productive than bringing in unvalidated online test results.

References

Ajamian, M., Steer, D., Rosella, G., & Gibson, P. R. (2019). Serum zonulin as a marker of intestinal mucosal barrier function: May not be what it seems. PLOS ONE, 14(1), e0210728. https://doi.org/10.1371/journal.pone.0210728
Bischoff, S. C., Barbara, G., Buurman, W., Ockhuizen, T., Schulzke, J. D., Serino, M., Tilg, H., Watson, A., & Wells, J. M. (2014). Intestinal permeability: A new target for disease prevention and therapy. BMC Gastroenterology, 14, 189. https://doi.org/10.1186/s12876-014-0189-7
Camilleri, M. (2019). Leaky gut: Mechanisms, measurement and clinical implications in humans. Gut, 68(8), 1516-1526. https://doi.org/10.1136/gutjnl-2019-318427
Chakaroun, R. M., Massier, L., & Kovacs, P. (2020). Gut microbiome, intestinal permeability, and tissue bacteria in metabolic disease: Perpetrators or bystanders? Nutrients, 12(4), 1082. https://doi.org/10.3390/nu12041082
Del Rio, E. A., Valenzano, M. C., DiGuilio, K. M., Rybakovsky, E., Kjelstrom, S., Montone, G., Mercogliano, G., Newman, G., Wong, P., Albert, N., Burris, V., Szymanski, K., Rodriguez, A., Hollis, E., Kossenkov, A., & Mullin, J. M. (2025). Orally administered zinc gluconate induces tight junctional remodeling and reduces passive transmucosal permeability across human intestine in a patient-based study. International Journal of Molecular Sciences, 26(17), 8540. https://doi.org/10.3390/ijms26178540
DiMattia, Z. J., Damani, J. J., Van Syoc, E., & Rogers, C. J. (2024). Effect of probiotic supplementation on intestinal permeability in overweight and obesity: A systematic review of randomized controlled trials and animal studies. Advances in Nutrition, 15(1), 100162. https://doi.org/10.1016/j.advnut.2023.100162
Dmytriv, T. R., Storey, K. B., & Lushchak, V. I. (2024). Intestinal barrier permeability: The influence of gut microbiota, nutrition, and exercise. Frontiers in Physiology, 15, 1380713. https://doi.org/10.3389/fphys.2024.1380713
Dunlop, S. P., Hebden, J., Campbell, E., Naesdal, J., Olbe, L., Perkins, A. C., & Spiller, R. C. (2006). Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes. American Journal of Gastroenterology, 101(6), 1288-1294.
Fasano, A. (2020). All disease begins in the (leaky) gut: Role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases. F1000Research, 9, 69. https://doi.org/10.12688/f1000research.20510.1
Hanning, N., Edwinson, A. L., Ceuleers, H., Peters, S. A., De Man, J. G., Hassett, L. C., De Winter, B. Y., & Grover, M. (2021). Intestinal barrier dysfunction in irritable bowel syndrome: A systematic review. Therapeutic Advances in Gastroenterology, 14, 1756284821993586. https://doi.org/10.1177/1756284821993586
Helander, H. F., & Fändriks, L. (2014). Surface area of the digestive tract revisited. Scandinavian Journal of Gastroenterology, 49(6), 681-689. https://doi.org/10.3109/00365521.2014.898326
Horowitz, A., Chanez-Paredes, S. D., Haest, X., & Turner, J. R. (2023). Paracellular permeability and tight junction regulation in gut health and disease. Nature Reviews Gastroenterology & Hepatology, 20(7), 417-432. https://doi.org/10.1038/s41575-023-00766-3
Khoshbin, K., & Camilleri, M. (2020). Effects of dietary components on intestinal permeability in health and disease. American Journal of Physiology-Gastrointestinal and Liver Physiology, 319(5), G589-G608. https://doi.org/10.1152/ajpgi.00245.2020
Lacy, B. E., Pimentel, M., Brenner, D. M., Chey, W. D., Keefer, L. A., Long, M. D., & Moshiree, B. (2021). ACG clinical guideline: Management of irritable bowel syndrome. American Journal of Gastroenterology, 116(1), 17-44. https://doi.org/10.14309/ajg.0000000000001036
Lacy, B. E., Wise, J. L., & Cangemi, D. J. (2024). Leaky gut syndrome: Myths and management. Gastroenterology & Hepatology, 20(5), 264-272. https://pubmed.ncbi.nlm.nih.gov/39193076/
Mu, Q., Kirby, J., Reilly, C. M., & Luo, X. M. (2017). Leaky gut as a danger signal for autoimmune diseases. Frontiers in Immunology, 8, 598. https://doi.org/10.3389/fimmu.2017.00598
National Institutes of Health, Office of Dietary Supplements. (2026). Zinc: Fact sheet for health professionals. https://ods.od.nih.gov/factsheets/Zinc-HealthProfessional/
Odenwald, M. A., & Turner, J. R. (2017). The intestinal epithelial barrier: A therapeutic target? Nature Reviews Gastroenterology & Hepatology, 14, 9-21. https://doi.org/10.1038/nrgastro.2016.169
Rubio-Tapia, A., Hill, I. D., Semrad, C., Kelly, C. P., & Lebwohl, B. (2023). American College of Gastroenterology guidelines update: Diagnosis and management of celiac disease. American Journal of Gastroenterology, 118(1), 59-76. https://doi.org/10.14309/ajg.0000000000002075
Sturgeon, C., & Fasano, A. (2016). Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases. Tissue Barriers, 4(4), e1251384. https://doi.org/10.1080/21688370.2016.1251384
Zhang, J., Wang, T., Mao, X., Hu, X., Lv, L., Qi, H., & Zheng, L. (2025). Biomarkers in body fluids and their detection techniques for human intestinal permeability assessment. Clinical Chemistry and Laboratory Medicine, 63(11), 2115-2129. https://doi.org/10.1515/cclm-2025-0318
Zhou, Q., Verne, M. L., Fields, J. Z., Lefante, J. J., Basra, S., Salameh, H., & Verne, G. N. (2019). Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome. Gut, 68(6), 996-1002. https://doi.org/10.1136/gutjnl-2017-315136
Zuhl, M. N., Lanphere, K. R., Kravitz, L., Mermier, C. M., Schneider, S., Dokladny, K., & Mosher, P. (2014). Effects of oral glutamine supplementation on exercise-induced gastrointestinal permeability and tight junction protein expression. Journal of Applied Physiology, 116(2), 183-191. https://doi.org/10.1152/japplphysiol.00646.2013

Frequently Asked Questions

Can children have increased intestinal permeability or "leaky gut"?

Intestinal permeability is naturally higher in infancy and gradually tightens as the gut and immune system mature. This is normal and not a disease by itself. In children, conditions such as celiac disease, food allergies, and inflammatory bowel disease can involve increased intestinal permeability. Persistent digestive symptoms, poor growth, or food refusal warrant pediatric evaluation. Support children with a varied, age-appropriate diet and avoid giving multiple supplements marketed for leaky gut without guidance from a pediatric clinician.

Is bone broth necessary to heal a leaky gut?

Bone broth is not required for intestinal healing. There is currently limited direct human evidence showing that bone broth alone improves intestinal permeability. Depending on how it is made, it may provide some protein and can be a comforting food, but it should not be seen as a magic solution. Readers with vegetarian or vegan diets, or those who simply dislike bone broth, can focus on other protein sources and gut-supportive foods without feeling disadvantaged.

Does coffee damage the gut lining or cause leaky gut?

For most healthy adults, moderate coffee intake does not appear to damage the intestinal barrier in a clinically meaningful way according to current evidence. Some people with reflux, irritable bowel syndrome, or anxiety find that coffee worsens their symptoms. In those cases, reducing the amount or choosing decaffeinated coffee can be reasonable. Overall diet, stress, sleep, and underlying disease are far more important for gut health than a single beverage.

Can I improve intestinal permeability if I have both IBS and IBD?

Some people meet criteria for irritable bowel syndrome on top of a diagnosis like Crohn's disease or ulcerative colitis, especially when inflammatory markers are controlled but symptoms persist. A dual approach is often helpful: continuing IBD-specific medical therapy to maintain remission while using IBS strategies like gentle diet adjustments, stress management, and sometimes gut-directed psychological therapies. Changes should always be coordinated with the gastroenterology team to avoid flares or nutrient deficiencies.

Are there simple daily habits that help maintain a healthy intestinal barrier long term?

Eat mostly minimally processed foods with plenty of plants, include some fermented foods if tolerated, move your body most days, aim for regular sleep, manage stress in ways you enjoy, and attend recommended medical checkups. These habits support overall gut health, but none has been proven to treat a stand-alone leaky gut syndrome. Choose one or two small, realistic changes to start with rather than overhauling everything at once, and notice how your gut responds over time.